Factor V Leiden paradox: risk of deepvein thrombosis but not of pulmonary embolism

[1]  V. Nicaud,et al.  Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. , 2001, The American journal of medicine.

[2]  T. Perneger,et al.  Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism , 2000, British journal of haematology.

[3]  J. Nilsson,et al.  Location and Extent of Deep Vein Thrombosis in Patients with and without FV:R 506Q Mutation , 2000, Thrombosis and Haemostasis.

[4]  M. Prins,et al.  Is the Prevalence of the Factor V Leiden Mutation in Patients with Pulmonary Embolism and Deep Vein Thrombosis Really Different? , 1999, Thrombosis and Haemostasis.

[5]  K. Mann,et al.  Increased Tissue Factor-initiated Prothrombin Activation as a Result of the Arg506 → Gln Mutation in Factor VLEIDEN * , 1997, The Journal of Biological Chemistry.

[6]  T. Baglin,et al.  Relative Risk of Pulmonary Embolism and Deep Vein Thrombosis in Association with the Factor V Leiden Mutation in a United Kingdom Population , 1997, Thrombosis and Haemostasis.

[7]  P. Mannucci,et al.  Low Prevalence of Factor V:Q506 in 41 Patients with Isolated Pulmonary Embolism , 1997, Thrombosis and Haemostasis.

[8]  P. Reitsma,et al.  Risk Factor Profiles in Patients with Different Clinical Manifestations of Venous Thromboembolism: A Focus on the Factor V Leiden Mutation , 1996, Thrombosis and Haemostasis.

[9]  P. Simioni,et al.  An Antifibrinolytic Mechanism Describing the Prothrombotic Effect Associated with Factor VLeiden* , 1996, The Journal of Biological Chemistry.

[10]  P. Moerloose,et al.  Resistance to activated protein C in an unselected population of patients with pulmonary embolism , 1996, The Lancet.

[11]  P. Casey,et al.  Arachidonate and Related Unsaturated Fatty Acids Selectively Inactivate the Guanine Nucleotide-binding Regulatory Protein, G(*) , 1996, The Journal of Biological Chemistry.

[12]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[13]  B. Dahlbäck,et al.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.